Results 251 to 260 of about 824,404 (357)

Assessment of heated herbal products' tobacco harm reduction potential: pre-clinical and clinical studies. [PDF]

Front Toxicol
Marinas-Lacasta AF, Fearon IM, Stevenson M, Abusalem T, Chapman F, Trelles Sticken E, Wieczorek R, Pour SJ, Dethloff O, Komini O, Brown M, Simms L, Nahde T.   +12 more
europepmc   +1 more source

Downregulation of sST2, a decoy receptor for interleukin‐33, enhances subcutaneous tumor growth in murine pancreatic cancer cells

FEBS Open Bio, EarlyView.
Subcutaneous implantation of murine Panc02 pancreatic cancer cells depleted of sST2, a soluble decoy receptor for the proinflammatory interleukin‐33 (IL‐33), leads to a decreased number of GLUT4‐positive cancer‐associated adipocytes, reduced levels of the anti‐inflammatory molecule adiponectin, increased phosphorylation of IκBα, elevated Cxcl3 ...
Miho Akimoto, Nobuko Koshikawa, Takao Morinaga, Mimi Tamamori‐Adachi, Atsushi Takatori, Keizo Takenaga   +5 more
wiley   +1 more source

Implementation of Harm Reduction Syringe Services Programs at 2 Veterans Affairs Medical Centers. [PDF]

Fed Pract
Burkett M, Litke J, Percy A, Plank K, Richardson K, Kirkland M.   +5 more
europepmc   +1 more source

Harm Reduction Product Distribution in British Columbia

, 2008
Stephanie Harvard, Warren D. Hill, Jane A. Buxton   +2 more
openalex   +2 more sources

Cis‐unsaturated sphingolipids support growth of sphingoid base‐deficient yeast but impair plasma membrane integrity

FEBS Open Bio, EarlyView.
Sphingoid base structures, the sphingolipid backbones, vary among species. We established yeast cells in which the native sphingoid base was replaced with plant‐type bases containing cis or trans double bonds. This is, to our knowledge, the first eukaryotic model mostly composed of sphingolipids containing cis‐unsaturated sphingoid base, providing a ...
Takashi Higuchi, Saki Sugihara, Yohei Ishibashi, Kono Yushi, Hazuki Yamauchi, Motohiro Tani   +5 more
wiley   +1 more source

Walking a tightrope: a scoping review of the use, perceptions and experiences of harm reduction strategies in self-harm management. [PDF]

Discov Ment Health
Gunnarsson NV, Moberg C.
europepmc   +1 more source

Harm reduction and human rights: finding common cause

, 2008
Jonathan Cohen, Daniel Wolfe
openalex   +1 more source

Statins induce monocytic differentiation in acute myeloid leukemia cells through the KLF4/DPYSL2A axis

FEBS Open Bio, EarlyView.
Statins, identified via the Comparative Toxicogenomics Database, promote monocytic differentiation and apoptosis in non‐APL AML cells by upregulating DPYSL2A through a KLF4‐dependent pathway. Mevalonate supplementation reversed these effects, indicating involvement of the mevalonate pathway.
Mina Noura, Kota Shoji, Michidai Nobe, Moe Ishikawa, Miu Tanaka, Akiko Okayama, Souichi Adachi, Hidemasa Matsuo   +7 more
wiley   +1 more source

Revisiting Afghanistan's Drug Policy: A Policy Analysis of Eradication, Harm Reduction, and Economic Dependencies. [PDF]

Health Sci Rep
Azizi MQ, Wardak MF, Afzali E, Rahimi A, Ogaya JB, Ejaz E, Hasin BA, Masudi M, Lucero-Prisno DE.   +8 more
europepmc   +1 more source

Microbial profile of the appendix niche in acute appendicitis: a novel sampling approach

FEBS Open Bio, EarlyView.
This study utilized a novel sampling method, ERAT (i.e. endoscopic retrograde appendicitis treatment)‐guided lumen aspiration, to obtain samples from the appendix, and shotgun metagenomic sequencing was performed for in situ characterization of the appendix microbiome in patients with acute appendicitis.
Huimin Ma, Mingfei Wang, Yanhu Feng, Wanqi Zhang, Wenbo Wang, Yanfeng Xie, Guixiang Kong, Jie Feng, Pengfei Wang, Qi Wang, Xiaojun Huang   +10 more
wiley   +1 more source